Decibel Therapeutics, Inc. Restructuring Charges
Decibel Therapeutics, Inc. reported Restructuring Charges of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2022-03-18
- Decibel Therapeutics, Inc. restructuring charges for the quarter ending 2020-12-31 was $0.00.
- Decibel Therapeutics, Inc. restructuring charges for the quarter ending 2020-09-30 was $0.00.
- Decibel Therapeutics, Inc. restructuring charges for the quarter ending 2020-06-30 was $554.00K.
- Decibel Therapeutics, Inc. restructuring charges for the quarter ending 2020-03-31 was $2.92M.
- Decibel Therapeutics, Inc. restructuring charges for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Decibel Therapeutics, Inc. restructuring charges for fiscal 2020 was $3.47M.
| Period end | Restructuring Charges | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-18 | ||||
| 2021-04-01 | $0.00 10-Q · filed 2021-11-10 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-18 | $554.00K derived: sum of 3 quarters · filed 2022-03-18 | $3.47M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $554.00K derived: sum of 2 quarters · filed 2022-03-18 | $3.47M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $554.00K 10-K · filed 2022-03-18 | $3.47M 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | $2.92M 10-K · filed 2022-03-18 |